These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8079814

  • 1. Groups I, II and III extracellular phospholipases A2: selective inhibition of group II enzymes by indomethacin but not other NSAIDs.
    Lobo IB, Hoult JR.
    Agents Actions; 1994 Mar; 41(1-2):111-3. PubMed ID: 8079814
    [Abstract] [Full Text] [Related]

  • 2. Effect of a series of 1-alkyl ether lipids on inhibition of phospholipase A2 activity and PAF responses.
    Kohler C, Carroll M, Tarrant E, Torley L, Wissner A.
    Inflammation; 1993 Jun; 17(3):245-61. PubMed ID: 8330926
    [Abstract] [Full Text] [Related]

  • 3. Effect of crotapotin and heparin on the rat paw oedema induced by different secretory phospholipases A2.
    Landucci EC, Toyama M, Marangoni S, Oliveira B, Cirino G, Antunes E, de Nucci G.
    Toxicon; 2000 Feb; 38(2):199-208. PubMed ID: 10665801
    [Abstract] [Full Text] [Related]

  • 4. Isolation and characterization of an endogenous inhibitor of phospholipase A2 from Indian cobra (Naja naja naja) venom.
    Rudrammaji LM, Gowda TV.
    Toxicon; 1998 Apr; 36(4):639-44. PubMed ID: 9643477
    [Abstract] [Full Text] [Related]

  • 5. Recombinant human type II phospholipase A2 lacks edema producing activity in rat.
    Morgan DW, Anderson CM, Meyers KP.
    Eur J Pharmacol; 1993 Apr 22; 235(1):45-50. PubMed ID: 8519280
    [Abstract] [Full Text] [Related]

  • 6. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.
    Garcia-Pastor P, Randazzo A, Gomez-Paloma L, Alcaraz MJ, Paya M.
    J Pharmacol Exp Ther; 1999 Apr 22; 289(1):166-72. PubMed ID: 10087000
    [Abstract] [Full Text] [Related]

  • 7. Petrosaspongiolides M-R: new potent and selective phospholipase A2 inhibitors from the New Caledonian marine sponge Petrosaspongia nigra.
    Randazzo A, Debitus C, Minale L, García Pastor P, Alcaraz MJ, Payá M, Gomez-Paloma L.
    J Nat Prod; 1998 May 22; 61(5):571-5. PubMed ID: 9599251
    [Abstract] [Full Text] [Related]

  • 8. PX-52, A novel inhibitor of 14 kDa secretory and 85 kDa cytosolic phospholipases A2.
    Franson RC, Rosenthal MD.
    Adv Exp Med Biol; 1997 May 22; 400A():365-73. PubMed ID: 9547578
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of phospholipase A2 purified from human herniated disc.
    Carabaza A, Cabré F, García AM, Gómez M, Sánchez J, Mauleón D, Carganico G.
    Biochem Pharmacol; 1993 Feb 09; 45(3):783-6. PubMed ID: 8442777
    [Abstract] [Full Text] [Related]

  • 10. Group IIA secretory PLA2 inhibition by ursolic acid: a potent anti-inflammatory molecule.
    Nataraju A, Raghavendra Gowda CD, Rajesh R, Vishwanath BS.
    Curr Top Med Chem; 2007 Feb 09; 7(8):801-9. PubMed ID: 17456043
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of venom phospholipases A2 by manoalide and manoalogue. Stoichiometry of incorporation.
    Reynolds LJ, Mihelich ED, Dennis EA.
    J Biol Chem; 1991 Sep 05; 266(25):16512-7. PubMed ID: 1885583
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antiinflammatory action of thielocin A1 beta, a group II phospholipase A2 specific inhibitor, in rat carrageenan-induced pleurisy.
    Tanaka K, Kato T, Matsumoto K, Yoshida T.
    Inflammation; 1993 Apr 05; 17(2):107-19. PubMed ID: 8491510
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. PLA2 activity in rat liver nuclei.
    van der Klis FR, Wiersinga WM.
    Int J Biochem; 1993 Apr 05; 25(4):575-9. PubMed ID: 8467957
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of manoalide on secreted and intracellular phospholipases.
    Bennett CF, Mong S, Clarke MA, Kruse LI, Crooke ST.
    Biochem Pharmacol; 1987 Mar 01; 36(5):733-40. PubMed ID: 3103628
    [Abstract] [Full Text] [Related]

  • 17. Vasoactive intestinal peptide and helodermin inhibit phospholipase A2 activity in vitro.
    Trotz ME, Said SI.
    Regul Pept; 1993 Nov 03; 48(3):301-7. PubMed ID: 8278623
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Selective inhibition of group II phospholipase A2 by quercetin.
    Lindahl M, Tagesson C.
    Inflammation; 1993 Oct 03; 17(5):573-82. PubMed ID: 8225564
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.